Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Deals & Financings

VC fundings, mergers and acquisitions, and other financing events...

Impact Sells Rights for Two PARP Inhibitors to Eikon Therapeutics

invoX Makes 2nd Investment in pHion, a Belfast mRNA Vaccine Company

Lynk Pharma Closes C1 Round with $28 Million for Oncology and Autoimmune Drugs

Betta Signs $392 Million Agreement for Lung Cancer Drug Rights with C4 Therapeutics

Coherent Bio Closes B Round with $100 Million for XDC Candidates

ChinaBio Event
September 20-21 | Shanghai
September 25-26 | Digital
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China